Targeted nanoparticle drug delivery platform for CNS therapeutics
Our lab has developed a lipid-polymer hybrid nanoparticle platform capable of crossing the blood-brain barrier with 3x higher penetration efficiency than conventional PEGylated liposomes in murine models. The platform us...